Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Clinical Manifestations and Treatment of Wegener's Granulomatosis

Julia U. Holle*, Martin Laudien, Wolfgang L. Gross

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Wegener's granulomatosis (WG) is characterized by granulomatous lesions and vasculitic disease manifestations. Granulomatous lesions are found in the upper and lower respiratory tract (eg, granulomatous sinusitis, orbital masses, and pulmonary granuloma), whereas vasculitic manifestations occur frequently in lung (alveolar hemorrhage) and kidney (glomerulonephritis). Vasculitis is typically associated with antineutrophil cytoplasmic antibodies (ANCA) directed against proteinase 3. WG has been traditionally associated with a poor outcome and increased mortality as documented by numerous studies; however, recent cohort studies report an improved outcome, probably a consequence of increased awareness leading to an earlier diagnosis, and to improved treatment strategies derived from evidence from controlled trials. Treatment regimens for WG, adapted to disease stage and activity, are reviewed and discussed in this article.
OriginalspracheEnglisch
ZeitschriftRheumatic Disease Clinics of North America
Jahrgang36
Ausgabenummer3
Seiten (von - bis)507-526
Seitenumfang20
ISSN0889-857X
DOIs
PublikationsstatusVeröffentlicht - 01.08.2010

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Fingerprint

Untersuchen Sie die Forschungsthemen von „Clinical Manifestations and Treatment of Wegener's Granulomatosis“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren